Three Astellas Research and Production Facilities in Japan Adopt Aqua Premium
(WorldNews Japan)

- Switching to greenhouse gas emission-free hydroelectric power - TOKYO, April 6, 2020 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., `Astellas`) today announced that three of its research and production facilities in Japan will be changing their electricity supply plan to the Aqua Premium1 plan offered by TEPCO Energy Partner, Inc., starting in April 2020. With this change, all electricity...